Urologic considerations in Bartter's syndrome.
D000293:Adolescent; D000328:Adult; D001706:Biopsy; D002348:Carpal Bones; D005260:Female; D005528:Foot; D006801:Humans; D006869:Hydronephrosis / Q000000981:diagnostic imaging / Q000209:etiology; D006929:Hyperaldosteronism / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D007008:Hypokalemia / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D007606:Juxtaglomerular Apparatus / Q000473:pathology*; D007668:Kidney / Q000473:pathology; D007674:Kidney Diseases / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D011188:Potassium / Q000627:therapeutic use; D011507:Proteinuria / Q000209:etiology; D011859:Radiography; D013035:Spasm / Q000188:drug therapy / Q000209:etiology; D013148:Spironolactone / Q000627:therapeutic use; D013577:Syndrome; D014515:Ureteral Diseases / Q000000981:diagnostic imaging / Q000209:etiology; D001743:Urinary Bladder / Q000000981:diagnostic imaging
D013148:Spironolactone; D011188:Potassium